R Squared’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$243K Buy
+4,129
New +$252K 0.13% 283
2025
Q1
– Sell
-3,050
Closed -$53.1K – 1436
2024
Q4
$53.1K Buy
+3,050
New +$53.9K 0.05% 477

Other funds holding TVTX

R Squared's TVTX Position: Q3 2026 in Review

R Squared opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 4,129 shares worth $243K. The stake represents 0.13% of the portfolio and ranks #283 among its holdings. This is a return to the name: R Squared previously reported a position in TVTX as recently as Q4 2024.

R Squared first reported a position in TVTX in Q4 2024 and has held it in 2 quarters since. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • R Squared held 4,129 shares of Travere Therapeutics worth $243K as of Q3 2026.
  • Travere Therapeutics was a new R Squared position in Q3 2026.
  • Travere Therapeutics made up 0.13% of R Squared's portfolio in Q3 2026, its #283 holding.
  • R Squared first reported a position in Travere Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on R Squared's 13F filing for Q3 2026, filed 6 Nov 2026.